ABOzymes

Vancouver, Canada Founded: 2020 • Age: 6 yrs
Blood transfusion services are provided by ABOzymes in healthcare settings.
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors 8 Brand Intelligence

About ABOzymes

ABOzymes is a company based in Vancouver (Canada) founded in 2020. ABOzymes operates in a competitive market with competitors including Versiti, Osterreichisches Rotes Kreuz, CSL Plasma, Vitalant and The Blood Connection, among others.

  • Headquarter Vancouver, Canada
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Mitacs

    & 2 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ABOzymes

Investors in ABOzymes

ABOzymes has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Mitacs, Genome British Columbia and Canadian Glycomics Network.

All
Institutional
Investor Description Founded Year Domain Location
Funds genomics research in health, forestry, fisheries, and education sectors.
Locked Locked Locked
Research and innovation in glycomics are advanced by GlycoNet.
Locked Locked Locked
A foundation focused on economic development
Locked Locked Locked
Premium access

Investor details for ABOzymes

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ABOzymes

Investments
Premium access

Investment portfolio details for ABOzymes

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ABOzymes

Premium access

Detailed financials for ABOzymes

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Abozymes Comparisons

ABOzymes Primary company
Description
Blood transfusion services are provided by ABOzymes in healt...
Location
Vancouver, Canada
Founded Year
2020
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ABOzymes

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ABOzymes

ABOzymes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Versiti, Osterreichisches Rotes Kreuz, CSL Plasma, Vitalant and The Blood Connection, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Blood bank
Locked Locked Locked
Blood donation services are provided across Austria by the organization.
Locked Locked Locked
CSL Plasma provides plasma collection services
Locked Locked Locked
Nonprofit blood and biotherapies services are delivered nationwide by Vitalant.
Locked Locked Locked
Facilitates blood donations, hosts drives, and partners with hospitals for community health.
Locked Locked Locked
Manages blood donations, drives, and medical services for hospitals and donors.
Premium access

Detailed competitors of ABOzymes

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Abozymes

Premium access

Complete news archive for ABOzymes

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ABOzymes

ABOzymes was founded in 2020 and raised its 1st funding round 1 year after it was founded.

ABOzymes is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.

ABOzymes was established in 2020 and is based in Vancouver, Canada. Operations center on blood transfusion services within the healthcare sector. Matching and delivery of blood components are handled to support medical procedures. The company maintains a domain at abozymes.com for its activities. Focus remains on standard protocols for transfusion safety and efficiency across regional facilities.

ABOzymes's top competitors include Versiti, CSL Plasma and Vitalant.

ABOzymes has 3 investors. Key investors include Mitacs, Genome British Columbia, and Canadian Glycomics Network.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available